Cannabinoids and opioid consumption in cancer pain: a systematic review and meta-analysis
Abstract Background: Opioids are the mainstay of cancer-related pain management but are limited by adverse effects and clinical complexity. Cannabinoids…
Abstract Background: Opioids are the mainstay of cancer-related pain management but are limited by adverse effects and clinical complexity. Cannabinoids…
Abstract Growing evidence shows that brain aging is a time-dependent process, with very complex underlying mechanisms at molecular and cellular…
Abstract Background: Cannabinoids are studied as anticancer agents, but their effects vary across tumors, compounds, and experimental settings, underscoring the…
Abstract Introduction and Aim: Assessment of antitumor activity in preclinical models remains challenging when relying solely on conventional size-based imaging,…
Abstract Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and frequently co-occurs with chronic pain.…
Abstract Aging is characterized in part by chronic, low-grade inflammation, a major driver of cognitive decline, metabolic imbalance and organ…
Abstract Introduction: Cannabinoids hold promise in oncology for symptom relief and antitumor effects, though concerns about safety and efficacy persist.…
Abstract Background: Aging is a multifaceted process marked by the progressive accumulation of cellular damage in various tissues, resulting in…
Abstract Purpose of the Review: As cancer survival rates are increasing, alternative treatments to improve quality of life, such as…
Abstract The increasing prevalence of dementia within an ageing global population, combined with prolonged life expectancy, accentuates Alzheimer’s disease (AD)…